Abhimanyu Garg, M.D.
- Professor of Internal Medicine
- Chief, Division of Nutrition and Metabolic Diseases
- Director of Metabolic Diseases in the Center for Human Nutrition
- Distinguished Chair in Human Nutrition Research
Dr. Garg is the leading expert worldwide on lipodystrophy treatment and research. He was the first researcher to test the hormone leptin as treatment for lipodystrophy as part of a clinical trial that started at UT Southwestern in 2000. In 2014, the U.S. Food and Drug Administration approved the drug form of leptin for treatment of generalized lipodystrophy.
Need 5-10 publications and a link to Dr. Garg's Pubmed list